Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?

Autor:	Dintakurti SH; Imperial College London, London, UK., Kamath S; Department of Imaging, Royal Brompton Hospital, London, UK., Mahon C; Department of Imaging, Royal Brompton Hospital, London, UK., Singh S; Department of Adult Intensive Care, Royal Brompton Hospital, London, UK., Rawal B; Department of Imaging, Royal Brompton Hospital, London, UK., Padley SPG; Department of Imaging, Royal Brompton Hospital, London, UK., Devaraj A; Department of Imaging, Royal Brompton Hospital, London, UK., Price LC; Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK., Desai SR; Department of Imaging, Royal Brompton Hospital, London, UK., Semple T; Department of Imaging, Royal Brompton Hospital, London, UK., Ridge CA; Department of Imaging, Royal Brompton Hospital, London, UK.
Jazyk:	angličtina
Zdroj:	ERJ open research [ERJ Open Res] 2023 Feb 06; Vol. 9 (1). Date of Electronic Publication: 2023 Feb 06 (Print Publication: 2023).
DOI:	10.1183/23120541.00389-2022
Abstrakt:	In situ pulmonary arterial thrombosis in COVID-19 is not visible on CTPA. However, the presence of CT-measured right heart and pulmonary artery dilatation in COVID-19 is likely attributable to this process and may be a possible surrogate for its detection. https://bit.ly/3g7z5TV. Competing Interests: Conflict of interest: L.C. Price has received support from Janssen Pharmaceuticals and Ferrer Pharmaceuticals to attend meetings outside the submitted work, and participated on a data safety or advisory board for Janssen outside the submitted work. The remaining authors have nothing to disclose. (Copyright ©The authors 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu